We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 41-60 of 1,394 results
  1. Designing Efficient Cascade Reactions in Drug Discovery

    This chapter focuses on the exploration and application of cascade reactions in the total synthesis of both biologically active natural products and...
    Chenguang Yu, He Huang, ... Wei Wang in Green Chemistry in Drug Discovery
    Protocol 2022
  2. Diabetes and Cancer: The Epidemiological and Metabolic Associations

    Diabetes mellitus, commonly known as diabetes, and cancer are two of the most common diseases plaguing the world today. According to the Centers for...
    Cissy Zhang, Anne Le in The Heterogeneity of Cancer Metabolism
    Chapter Open access 2021
  3. Diabetes as one of the long-term COVID-19 complications: from the potential reason of more diabetic patients’ susceptibility to COVID-19 to the possible caution of future global diabetes tsunami

    According to recent researches, people with diabetes mellitus (type 1 and 2) have a higher incidence of coronavirus disease 2019 (COVID-19), which is...

    Yasamin Sharbatdar, Ronak Mousavian, ... Fatemeh Kazemi-Lomedasht in Inflammopharmacology
    Article 20 April 2023
  4. Antidiabetics and Antilipemics from Nature

    In recent years, diabetes and hyperlipidemia have become common in people from all parts of the world. Both these diseases are characterized by...
    Vijayan Pallath Nimisha, Das Moozhikkal Mousumi in Drugs from Nature: Targets, Assay Systems and Leads
    Chapter 2024
  5. Advances in Cancer Therapeutics: Potential Probiotics on Cancer Therapy

    Cancer is known as the leading cause of human mortality. Several risk factors are associated with develo** cancer like genetic factors, immune...
    Asit Ranjan Ghosh, Jeneesha George in Handbook of Oncobiology: From Basic to Clinical Sciences
    Reference work entry 2024
  6. Resistin As a Biomarker and Applications to PreDiabetes

    Resistin is a cysteine-rich protein, secreted from mature human adipocytes. Resistin has 108 amino acids. The resistin coding gene area is located on...
    Seyfettin Üstünsoy in Biomarkers in Diabetes
    Living reference work entry 2022
  7. A nationwide cohort study on diabetes severity and risk of Parkinson disease

    There is growing evidence that patients with type 2 diabetes mellitus (DM) have an increased risk of develo** Parkinson’s disease (PD) and share...

    Kyungdo Han, Bongsung Kim, ... Mee Kyoung Kim in npj Parkinson's Disease
    Article Open access 27 January 2023
  8. Polygenic subtype identified in ACCORD trial displays a favorable type 2 diabetes phenotype in the UKBiobank population

    Introduction

    We previously identified a genetic subtype (C4) of type 2 diabetes (T2D), benefitting from intensive glycemia treatment in the Action to...

    Courtney Hershberger, Arshiya Mariam, ... Daniel M. Rotroff in Human Genomics
    Article Open access 22 June 2024
  9. Sex differences in type 2 diabetes: an opportunity for personalized medicine

    Over the past several decades, substantial ground has been gained in understanding the biology of sex differences. With new mandates to include sex...

    Meredith L. Johnson, Joshua D. Preston, ... J. Nina Ham in Biology of Sex Differences
    Article Open access 13 December 2023
  10. Insulin Resistance and Cancer

    Insulin is a peptide hormone that mediates both metabolic and mitogenic effects, and impaired insulin signaling leads to insulin resistance with...
    Adriana Monroy, Laura Gómez-Laguna, ... Silvestre Alavez in Handbook of Oxidative Stress in Cancer: Mechanistic Aspects
    Reference work entry 2022
  11. Osteoporosis

    Osteoporosis is a systemic skeletal disease associated with an increased risk of fracture and characterized by reduced bone mass and qualitative...
    Marcella Montini, Alessandra Ana Maria Pagani, ... Elena Vittoria Longhi in Managing Psychosexual Consequences in Chronic Diseases
    Chapter 2023
  12. PPAR Modulation Through Posttranslational Modification Control

    The peroxisome proliferator-activated receptors (PPAR) are transcription factors modulated by ligands and members of the nuclear receptor...
    Natália B. Videira, Marieli M. G. Dias, ... Ana Carolina M. Figueira in Nuclear Receptors
    Chapter 2021
  13. Insulin Receptor

    André Kleinridders, Hans-Georg Joost in Encyclopedia of Molecular Pharmacology
    Reference work entry 2021
  14. A new class of drug in the diabetes toolbox

    Klara R. Klein, John B. Buse in Nature Medicine
    Article 12 May 2022
  15. Insulin Receptor

    André Kleinridders, Hans Georg Joost in Encyclopedia of Molecular Pharmacology
    Living reference work entry 2021
  16. Diabetes and Cancer

    Diabetes mellitus and cancer are two heterogeneous diseases, incidence of both of which is increasing. Epidemiological evidences suggest that cancer...
    Chapter 2022
  17. Natural Products as Nano-Antidiabetic Drugs

    Natural products have emerged as promising candidates for the development of nano-antidiabetic drugs, presenting a novel approach to combat the...
    Thottukara Madathil Archana, Sudhakaran Sudheesh in Drugs from Nature: Targets, Assay Systems and Leads
    Chapter 2024
  18. Polypharmacology in Clinical Applications: Metabolic Disease Polypharmacology

    Metabolic diseases consisting of different groups of disorders are becoming increasingly prevalent and have a major impact on public health...
    Zhiguo Wang, Baofeng Yang in Polypharmacology
    Chapter 2022
Did you find what you were looking for? Share feedback.